Ignite Creation Date:
2025-12-24 @ 10:06 PM
Ignite Modification Date:
2025-12-28 @ 5:57 PM
Study NCT ID:
NCT01934335
Status:
TERMINATED
Last Update Posted:
2021-11-01
First Post:
2013-08-29
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Effect of Vandetanib on Cellular Markers in Invasive Breast Cancer
Sponsor:
Ronald Weigel
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2013-10
Start Date Type:
ACTUAL
Primary Completion Date:
2018-12-21
Primary Completion Date Type:
ACTUAL
Completion Date:
2018-12-21
Completion Date Type:
ACTUAL
First Submit Date:
2013-08-29
First Submit QC Date:
None
Study First Post Date:
2013-09-04
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2021-05-13
Results First Submit QC Date:
None
Results First Post Date:
2021-11-01
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2021-10-01
Last Update Post Date:
2021-11-01
Last Update Post Date Type:
ACTUAL